Decent expected Growth:
| Market Cap (intraday) 5 | 116.21B |
| Enterprise Value 3 | 131.89B |
| Trailing P/E | 37.87 |
| Forward P/E 1 | 15.46 |
In a promising field: medicine and technology
So so recent sales growth:
| Quarterly Revenue Growth (yoy) | 2.90% |
Nice recent Earning growth:
Quarterly Earnings Growth (yoy)25.50%
Great dividends for an healthy technology company:
| Forward Annual Dividend Rate 4 | 1.84 |
| Forward Annual Dividend Yield 4 | 2.12% |
Leave a comment